Remarkable Results of the Mayo Clinic’s Phase I Clinical Trial on Stem Cell Therapy for Spinal Cord Injury
Results from a recent groundbreaking study conducted by the Mayo Clinic have ignited hope for individuals living with the devastating consequences of spinal cord injuries (SCI). This Phase I clinical trial, published in Nature, explored the safety and potential benefits of intrathecal delivery of adipose-derived mesenchymal stem cells (AD-MSCs) in patients with traumatic SCI.
Study Design
The CELLTOP (Clinical Trial of Autologous Adipose-Derived Mesenchymal Stem Cells in the Treatment of Paralysis Due to Traumatic Spinal Cord Injury) trial enrolled 10 patients with traumatic SCI who were classified as American Spinal Injury Association Impairment Scale (AIS) grade A or B at the time of injury. The study’s primary objective was to evaluate the safety profile of the stem cell therapy, as captured by the nature and frequency of adverse events.
The treatment approach involved harvesting stem cells from the patients’ own stomach fat, expanding them in a laboratory to 100 million cells, and then delivering them via intrathecal injection into the lumbar spine. Secondary outcomes included changes in sensory and motor scores, imaging studies, cerebrospinal fluid markers, and somatosensory evoked potentials.
Study Results
Seven out of the ten patients demonstrated improvement in their AIS grade from the time of injection, indicating significant gains in motor function and sensation. One of the most inspiring stories is that of Chris Barr, the first participant in the study.
Barr, who had been paralyzed from the neck down after a surfing accident seven years prior, experienced a transformative recovery. After receiving stem cell therapy from the trial, along with physical rehabilitation and dedication to improvement, he regained the ability to stand and walk independently, a feat he had never dreamed possible. “I never dreamed I would have a recovery like this,” Barr told ABC News. “I can feed myself. I can walk around. I can do day-to-day independent activities.”
Safety & Tolerability, and Future Research
The study met its primary endpoint, demonstrating that the harvesting and administration of AD-MSCs were well-tolerated in patients with traumatic SCI. The most commonly reported adverse events were headaches and musculoskeletal pain, observed in 8 out of 10 patients. Importantly, no serious adverse events were observed throughout the study period.
While the results of the CELLTOP trial are promising, researchers acknowledge that further investigation is necessary to fully understand the mechanisms by which stem cells interact with the spinal cord and facilitate recovery. Additional studies are underway among a larger group of people to further assess the risks and benefits of this innovative therapy.
“This trial shows us that stem cells are safe and potentially beneficial in the treatment of spinal cord injury,” said Dr. Mohamad Bydon, a neurosurgeon and spinal cord researcher at the Mayo Clinic, who led the study. “This can be a milestone in our field of neurosurgery, neuroscience, and treating patients with spinal cord injury.”
Embrace the Future of Regenerative Medicine at STEMS Health
At STEMS Health, we are dedicated to staying at the forefront of groundbreaking research in regenerative medicine, including stem cell therapies for spinal cord injuries and other debilitating conditions. Our team of experienced healthcare professionals closely follows the latest developments in the field, ensuring that we offer cutting-edge treatments tailored to each individual’s unique needs.
If you or a loved one has been affected by injury or pain, we encourage you to schedule a consultation with our experts. Together, we can explore the potential of stem cell therapy and develop a personalized treatment plan that may help restore function, independence, and improve your overall quality of life.
Embrace the power of regenerative medicine and join us on the journey toward healing and recovery. Contact STEMS Health today to learn more about our stem cell therapy programs and take the first step towards reclaiming your mobility and living life to its fullest potential.
